Advance Your Program Through Target Product Profile Definition and Dose Design
Summary: In this exclusive webinar designed for drug developers and pharmaceutical and biotechnology consultants, experts review the importance of the Target Product Profile (TPP). Jim Spavins, Principal of Spavins Consulting, LLC and a former SVP of Pfizer’s industry-leading Pharmaceutical Sciences organization, gives his expert advice on developing a successful TPP. In addition, Catalent’s Nathan Bennette will introduce the new technology OptiDose® Design Solution, an integrated dose form design strategy based on the analysis of your molecule, patients and market. Learn how Catalent’s holistic development approach combines the API’s biopharmaceutic properties, Physiologically-Based Pharmacokinetic (PBPK) modeling, manufacturability, and target patient characteristics to support decision-making throughout the dosage form design process.